feed,title,long_url,short_url
InsiderMonkey,Coty Completes Wella Divestment to Refocus on Fragrances,https://insidermonkey.com/blog/--1663486,
InsiderMonkey,Denison Mines Forms Joint Ventures With Skyharbour,https://insidermonkey.com/blog/--1663491,
InsiderMonkey,Jefferies Sees Structural Strength but Limited Upside for UWM Holdings Corporation (UWMC),https://insidermonkey.com/blog/--1663500,
InsiderMonkey,Wall Street Keeps B2Gold Corp. (BTG) in Focus With Mixed Views,https://insidermonkey.com/blog/--1663503,
InsiderMonkey,BlackBerry Limited (BB) Outperforms Estimates but RBC Sticks With Sector Perform,https://insidermonkey.com/blog/--1663505,
InsiderMonkey,NIO Inc. (NIO) Holds Mixed Analyst Sentiment Despite Strong Median Upside Potential,https://insidermonkey.com/blog/--1663507,
InsiderMonkey,Clarivate Plc (CLVT) Downgraded Amid Turnaround Challenges,https://insidermonkey.com/blog/--1663473,
InsiderMonkey,Cosan S.A. (CSAN) Gets Negative Outlook from Fitch as Leverage Remains High,https://insidermonkey.com/blog/--1663509,
InsiderMonkey,Bullish Analyst Sentiment on Fulcrum Therapeutics (FULC) Following Positive Updates from Phase 1b PIONEER Study,https://insidermonkey.com/blog/--1663452,
InsiderMonkey,Taysha Gene (TSHA) Hovers Around Its 52-Week High As It Continues to Advance Rett Syndrome Program,https://insidermonkey.com/blog/--1663453,
InsiderMonkey,High Analyst Confidence on Palvella Therapeutics (PVLA) Following Encouraging Phase 2 Data for QTORIN Rapamycin,https://insidermonkey.com/blog/--1663455,
InsiderMonkey,Gossamer Bio (GOSS) Sees Strong Analyst Confidence Amid Seralutinib Progress and Upcoming PROSERA Data,https://insidermonkey.com/blog/--1663456,
InsiderMonkey,Strong REZOLVE-AA Study Results Drive Analyst Confidence in Nektar Therapeutics (NKTR),https://insidermonkey.com/blog/--1663457,
InsiderMonkey,Trevi Therapeutics (TRVI) Targets Next Phase of Growth with Leadership Change,https://insidermonkey.com/blog/--1663429,
InsiderMonkey,Analysts Remain Bullish on Seabridge Gold (SA) Amid KSM Project Progress,https://insidermonkey.com/blog/--1663431,
InsiderMonkey,TD Cowen Initiates Coverage on RAPT Therapeutics (RAPT) with a “Buy”,https://insidermonkey.com/blog/--1663432,
InsiderMonkey,Analysts Bullish as Ventyx Biosciences (VTYX) Advances Its Clinical and Strategic Initiatives,https://insidermonkey.com/blog/--1663433,
InsiderMonkey,Analyst Sentiment Remains Bullish on CytomX Therapeutics (CTMX) Amid CX-2051 Therapy Progress,https://insidermonkey.com/blog/--1663428,
InsiderMonkey,H.C Wainwright and Citizens Raise PT on DBV Technologies (DBVT) Following Phase 3 VITESSE Trial Result,https://insidermonkey.com/blog/--1663430,
